NCT00422396View on ClinicalTrials.gov

Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Hypertriglyceridemia With the Metabolic Syndrome
Interventions
DRUG

Fenofibrate (drug)

Trial Locations (1)

60611

Northwestern University preventive Cardiology Center, Chicago

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Michigan

OTHER